1. Home
  2. KNSA vs AZZ Comparison

KNSA vs AZZ Comparison

Compare KNSA & AZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

HOLD

Current Price

$45.91

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Logo AZZ Inc.

AZZ

AZZ Inc.

HOLD

Current Price

$122.93

Market Cap

4.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
KNSA
AZZ
Founded
2015
1956
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
4.1B
IPO Year
2018
1994

Fundamental Metrics

Financial Performance
Metric
KNSA
AZZ
Price
$45.91
$122.93
Analyst Decision
Strong Buy
Buy
Analyst Count
7
5
Target Price
$55.29
$126.00
AVG Volume (30 Days)
672.2K
152.9K
Earning Date
04-28-2026
04-20-2026
Dividend Yield
N/A
0.67%
EPS Growth
225.00
N/A
EPS
0.75
9.97
Revenue
$677,564,000.00
$1,061,817,000.00
Revenue This Year
$38.01
$5.47
Revenue Next Year
$17.42
$6.13
P/E Ratio
$61.35
$11.96
Revenue Growth
60.09
14.53
52 Week Low
$18.26
$70.90
52 Week High
$49.12
$141.18

Technical Indicators

Market Signals
Indicator
KNSA
AZZ
Relative Strength Index (RSI) 51.92 42.69
Support Level $39.96 $120.20
Resistance Level $48.14 $127.88
Average True Range (ATR) 1.79 3.90
MACD -0.15 -0.92
Stochastic Oscillator 56.63 29.60

Price Performance

Historical Comparison
KNSA
AZZ

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

About AZZ AZZ Inc.

AZZ Inc is a provider of galvanizing and a variety of metal coating solutions and coil coating solutions to a broad range of end markets in North America. The company's operating segment consists of Metal Coatings, Precoat Metals, and Infrastructure Solutions. The company generates the majority of its revenue from the Precoat Metals segment, which provides coil coating application of protective and decorative coatings and related value-added downstream processing for steel and aluminum coils. Geographically, the company generates the majority of its revenue from the United States.

Share on Social Networks: